$200 Million
Joint Bookrunner
Follow-On
July 2023
UNDISCLOSED
Exclusive Financial Advisor
Merger with Tourmaline Bio
Pending
$250 Million
Joint Bookrunner
Follow-On
June 2023
$100 Million
Joint Bookrunner
Follow-On
June 2023
$137 Million
Joint Bookrunner
Follow-On
June 2023
$50 Million
Joint Bookrunner
Follow-On
June 2023
$159 Million
Joint Bookrunner
Secondary Offering
June 2023
UNDISCLOSED
Financial Advisor
Merger with Outcomes™, a Cardinal Health Business
Pending
$50 Million
Joint Bookrunner
Follow-On
May 2023
$40 Million
Joint Bookrunner
Follow-On
May 2023
$30 Million
Joint Bookrunner
Follow-On
May 2023
$350 Million
Joint Bookrunner
Follow-On
May 2023